Revealing dysbiosis

A dedicated team drive forward GA's product development, commercialization and sales

Sign up for our gut microbiota newsletter

GA will be a world leading molecular diagnostic company with core competence in mapping of microbiota, utilizing the GA-map technology to develop IVD tests in all diseases where microbiota is involved

Management


Ronny Hermansen (Chief Executive Officer)

More than 20 years of experience from the international diagnostic industry, including Nycomed Imaging, Nycomed Amersham and as CFO in Axis-Shield plc. Worked in GA since April 2014.


Emilie Lasson (Chief Commercial Officer)

Emilie has long experience from commercial and scientific leading positions within diagnostics pharma and medical nutrition. She has international experience among other from BASF (formerly Pronova) where she led a unit developing and commercializing products in medical nutrition. Holds a PhD in chemistry.


Christina Casèn (Clinical Director)

More than 20 years experience from international diagnostic industry. Holds a MSc in molecular biology.


Finn Terje Hegge (Chief Technical Officer)

PhD, Molecular biology (2004). Previously Lingvitae AS. Worked in GA since 2011.



--------------------------------------------------------------------------------------


Scientific Advisory Board


Dr. Lena Öhman

Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Sweden.


Professor Robert Löfberg

Gastroenterology, Karolinska Institute, Head of IBD unit, Sophia Hemmet, Sweden.


Professor Ole Haagen Nielsen

Head of Gastroenterology dept., Herlev Hospital, Copenhagen University, Denmark.


Professor Gerhard Rogler

Clinic for Gastroenterology and Hepatology, University of Zürich, Switzerland.


Professor Wolfgang Kruis

Head of Gastroenterology dept., Köln University Hospital, Germany.


Professor Lars Engstrand

Head of Swedish Institute for Infectious Disease Control/Karolinska Institute, Sweden; 25 years experience as a clinical microbiologist.


Professor Morten Vatn

Gastroenterology dept., Oslo University Hospital (Rikshospitalet), Member of International Faculty, Inflammatory Disease and Hepatology, Oslo University Hospital (Rikshospitalet), Norway.


--------------------------------------------------------------------------------------


Board of Directors


Ole Henrik Eriksen (Chairman)

Over 25 years experience in the pharma-, biotech- and medtech- industries, and has extensive experience in the development and financing of startup companies. He was the first CEO of Clavis Pharma (later Aqualis) and now holds a possition as VP Business Development in Weifa. Eriksen has previously been instrumental in two IPOs.


Stein Lorentzen-Lund (Board member)

Held position as CEO in a number of biotech startup companies Marketing and product manager experience from Johnson & Johnson, Sanofi Aventis and PhotoCure AS.


Dag Terje Rian (Board member)

Masters Degree (Siv.Ing) in Petroleum Engineering from NTNU, Norway. CEO and founder of Scandpower Petroleum Technology (SPT group) 1984-2006.


Knut Rudi (Board member)

Professor at Hedmark University College and The Norwegian University of Life Sciences. Inventor of the main patent behind GA.


Rune Sørum (Board member)

Senior adviser for European companies in the Far East and the Middle East 1983 - 1999. Executive position as founder and partner in a Norwegian investment company.